홈 > 시장보고서 > 의약품

시장보고서

상품코드

1408647

세계의 심장 이식 시장 : 규모, 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 - 수술 유형별, 유형별, 최종사용자별, 지역별

Heart Transplant Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Surgery Type, Type, End User, and Geography

발행일: 2023년 11월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 149 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 심장 이식 시장 규모는 2022년 154억 7,200만 달러로 2030년에는 354억 7,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 시장에 만연한 동향과 심장 이식 시장의 성장을 촉진하고 억제하는 요인에 초점을 맞추고 있습니다.

대상 질환의 이환율 증가와 노령인구의 증가가 시장 개척의 주요 요인입니다. WHO에 따르면 세계 고령화 인구는 2019년 10억 명에서 2050년 21억 명으로 증가할 것으로 예상되며, 고령 인구는 CVD, 정형외과 질환, 대사질환, 신경질환 등에 취약합니다. 그러나 높은 수술 비용이 심장 이식 시장의 성장을 가로막고 있습니다.

심장 이식 시장에서 활동하는 기업들은 제휴, 확장, 합의, 파트너십, 신제품 출시 등 전략적 개척에 주력하고 있으며, 이를 통해 매출 증대, 지리적 범위 확대, 기존 고객보다 더 많은 고객층에 대응할 수 있는 역량을 강화하는 데 기여하고 있습니다. 다음은 심장 이식 시장에서 주목할 만한 신흥국 시장 개척을 위한 몇 가지 사례입니다:

2021년 6월, Abbott Laboratories는 기계식 순환보조장치(MCS)인 Medtronic HeartWare 심실보조장치(HVAD)의 생산 능력과 공급 규모를 강화했습니다. 또한 HeartMate 3 심장 펌프를 환자에게 사용하고자 하는 의료 전문가를 위한 지원 교육 및 교육 프로그램을 제공한다고 발표했습니다.

2023년 3월, BiVACOR의 Cormorant Asset Management와 OneVentures는 OneVentures Healthcare Fund III를 통해 1,800만 달러의 자금을 지원했습니다. 이 자금은 회사가 주요 경영진을 고용하고 현재 진행 중인 연구개발 및 인간 임상시험의 초기 타당성 조사를 지원하는 데 사용됩니다. 이번 자금 지원으로 BiVACOR는 R&D 전문가와 경영진을 비롯한 핵심 인재를 채용하고 사업 규모를 두 배로 늘리기 위한 노력의 일환으로, 2023년 말까지 인간을 대상으로 한 첫 번째 인공심장 조기 타당성 시험을 실시하고자 합니다.

2022년 1월, BioVentrix는 알긴산 기반 주사 가능한 하이드로겔을 사용하여 심부전 진행을 막고 회복시키는 MateraCor, Inc.와 그 주요 제품을 인수했습니다.

2021년 9월, SynCardia Systems LLC는 캘리포니아에 본사를 둔 벤처캐피털 투자회사인 Hunniwell Lake Ventures, LLC에 인수되었습니다. 이번 인수로 SynCardia는 국내외 시장에서 지속적인 확장과 성공을 위한 경영 및 재정적 수단을 확보했습니다. 이번 자금 조달을 통해 회사는 최첨단 의료기기를 개발하고 새로운 적응증을 계속 개발할 수 있게 됐습니다.

심장 이식 시장은 수술 유형에 따라 동소성 심장 이식과 이종 심장 이식으로 구분되며, 2022년 동소성 심장 이식의 시장 점유율이 가장 크고 예측 기간 동안 11.1%의 CAGR을 기록할 것으로 예상됩니다. 동소성 심장 이식은 가장 일반적으로 사용되는 방법입니다. 동소성 접근법은 수혜자의 심장을 적출하고 기증자의 심장을 사용하여 해부학적으로 올바른 위치로 되돌려 놓는 방식입니다. 기증자의 심장을 적출한 후 운송을 위해 보관 및 포장하고, 4-5시간 이내에 수혜자에게 이식해야 합니다. 심장 이식이 진행되는 동안 수혜자는 전신 마취를 하고 혈액에 산소를 공급하기 위해 바이패스 장치를 설치합니다.

심장 이식 시장은 유형별로 기증자 생체 심장과 인공 심장으로 구분되며, 2022년 시장 점유율은 기증자 생체 심장 부문이 더 클 것으로 예상됩니다. 그러나 인공 심장 부문은 예측 기간 동안 11.6%의 높은 CAGR을 기록할 것으로 예상됩니다. 생체 기증자 이식은 사망한 사람의 심장을 떼어내어 심장이 더 이상 정상적으로 기능하지 않는 다른 사람에게 이식하는 수술법입니다. 이식용 장기의 수요가 급증하고, 사망자의 심장(자발적 기증을 통해 얻을 수 있는)이 부족하기 때문에 생체 장기 기증의 인기가 최근 들어 크게 증가하고 있습니다. 대부분의 기증자는 뇌사 판정 검사 후 사망 선고를 받습니다. 스스로 숨을 쉴 수 없어 인공호흡기에 연결되어 있지만 심장은 계속 뛰고 있습니다. 지난 40년 동안 이식된 심장은 모두 살아있는 기증자의 심장이었습니다.

심장 이식 시장은 최종사용자에 따라 병원, 심장 센터 및 기타로 분류됩니다. 병원 부문은 2022년 상당한 시장 점유율을 차지할 것으로 예상되며, 예측 기간 동안 11.2%의 높은 CAGR을 기록할 것으로 예상됩니다. 병원은 하나의 조직에서 여러 시설을 이용할 수 있는 대규모 조직입니다. 병원은 또한 보험 청구로 환급받을 수 있는 다양한 진단 및 치료 시설을 제공합니다. 병원은 더 나은 의료 서비스를 제공하기 위해 다양한 의사, 전문가 및 기타 의료 전문가를 고용하고 있습니다. 모든 CVD는 병원에서 치료할 수 있으며 간호 서비스도 잘 갖추어져 있습니다.

미국 식품의약국(USFDA), 임상경제성평가연구소(ICER), 질병통제예방센터(CDC)는 심장 이식 시장에 대한 보고서를 작성할 때 참고한 1차 및 2차 정보 중 일부입니다.

심장 이식 시장 : 주요 산업 역학
시장 성장 촉진요인
- 대상 질환 증가
- 노년 인구 증가
시장 성장 억제요인
- 수술 비용 급등
시장 기회
- 헬스케어 능력 향상과 신흥 국가의 환자수 증가
향후 동향
- 이식 수술의 AI 활용
성장 촉진요인과 억제요인의 영향

제6장 심장 이식 시장 : 세계 시장 분석

심장 이식 시장 매출, 2022-2030년
심장 이식 시장 예측과 분석

제7장 심장 이식 시장 분석 : 수술 유형

동소성 심장 이식
이소성 심장 이식

제8장 심장 이식 시장 분석 : 유형

공여자 생체 심장
인공심장

제9장 심장 이식 시장 분석 : 최종사용자

병원
심장 센터
기타

제10장 심장 이식 시장 : 지역별 분석

북미
유럽
아시아태평양
중동 및 아프리카
중남미

제11장 산업 상황

심장 이식 시장의 성장 전략
무기적 성장 전략
유기적 성장 전략

제12장 기업 개요

Terumo Corp
Evaheart Inc
Abbott Laboratories
SynCardia Systems LLC
BiVACOR Inc
BioVentrix Inc
Berlin Heart GmbH
LivaNova Plc
Jarvik Heart Inc
Calon Cardio-Technology Ltd

제13장 부록

ksm 24.01.24

According to our latest study on "Heart Transplant Market Forecast to 2030 - Global Analysis -Surgery Type, Type, and End User," the heart transplant market value is expected to reach US$ 35.470 billion by 2030 from US$ 15.472 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the heart transplant market.

The increasing target disease incidence and growing geriatric population are the key factors driving the market development. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. However, the high cost of surgeries hampers the growth of the heart transplant market.

Companies operating in the heart transplant market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the heart transplant market are mentioned below:

In June 2021, Abbott Laboratories enhanced its manufacturing capacity and supply scale for Medtronic HeartWare ventricular assist device (HVAD), a mechanical circulatory support (MCS) device. In addition, the company announced providing support training and education programs for healthcare professionals intending to use HeartMate 3 heart pumps in their patients.

In March 2023, BiVACOR Inc's Cormorant Asset Management and OneVentures, through OneVentures Healthcare Fund III, funded the company with US$ 18 million in capital. The funds will help the business hire important executives and support its ongoing R&D as well as early feasibility studies in human trials. Using this financial aid, the company would hire candidates for important roles, such as research and development professionals and the C-suite, as a part of its efforts to double its operations in size. BiVACOR Inc. further hopes to conduct an early feasibility study of its Total Artificial Heart for the first time in human subjects by the end of 2023.

In January 2022, BioVentrix Acquired MateraCor Inc. and its leading product. MateraCor, Inc. uses injectable hydrogel based on alginate to stop the progression of heart failure and reverse it.

In September 2021, SynCardia Systems LLC was acquired by the venture capital investment firm Hunniwell Lake Ventures, LLC, headquartered in California. With this acquisition, SynCardia has now gained the operational and financial means for its continued expansion and success in both domestic and international markets. The company has been able to continue creating cutting-edge medical devices and exploring new indications owing to this funding.

The heart transplant market, by surgery type, is segmented into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplant segment held a larger market share in 2022 and is anticipated to register a higher CAGR of 11.1% during the forecast period. An orthotopic heart transplant is the most commonly utilized technique. In the orthotopic approach, the recipient's heart is removed, and the donor's heart is used to restore it to the correct anatomical position. After the donor's heart is removed, it is preserved and packed for transport, and it must be transplanted into the receiver within 4-5 hours. While the heart transplant is being performed, general anesthesia is given to the receiver and is arranged on a bypass machine to oxygenate the blood.

The heart transplant market, by type, is segmented into donor live hearts and artificial hearts. The donor live heart segment held a larger market share in 2022. However, the artificial heart segment is anticipated to register a higher CAGR of 11.6% during the forecast period. A living donor transplant is an operating procedure to remove a heart from a dead person and place it in another person whose heart is no longer functioning properly. The popularity of living organ donation has increased significantly in recent years due to the burgeoning need for organs for transplantation and the shortage of hearts from deceased persons (obtained via voluntary donation). Most donors are declared dead after tests that determine brain death. Although they are kept on a ventilator as they can't breathe for themselves, their heart continues to beat. Traditionally, all transplanted hearts have come from living donors in the last 40 years.

The heart transplant market, by end-user, is segmented into hospitals, cardiac centers, and others. The hospitals segment held a substantial market share in 2022 and is predicted to register a higher CAGR of 11.2% during the forecast period. Hospitals are large entities that have multiple facilities available in a single organization. Hospitals also provide various diagnostics and treatment facilities that can be reimbursed under insurance claims. They employ various doctors, specialists, and other healthcare professionals to provide better healthcare services. All CVDs can be treated in hospitals, and they provide improved nursing services.

United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), and Centers for Disease Control and Prevention (CDC) are a few key primary and secondary sources referred to while preparing the report on the heart transplant market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the heart transplant market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global heart transplant market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global heart transplant market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Heart Transplant Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Heart Transplant Market - Key Industry Dynamics

5.1 Heart Transplant Market - Key Industry Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Target Disease Incidence
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 High Cost of Surgeries
5.4 Market Opportunities
- 5.4.1 Improving Healthcare Capabilities and Growing Patient Pool in Emerging Nations
5.5 Future Trends
- 5.5.1 Use of AI in Transplantation Procedures
5.6 Impact of Drivers and Restraints:

6. Heart Transplant Market - Global Market Analysis

6.1 Heart Transplant Market Revenue (US$ Million), 2022 - 2030
6.2 Heart Transplant Market Forecast and Analysis

7. Heart Transplant Market Analysis - Surgery Type

7.1 Overview
7.2 Orthotopic Heart Transplant
- 7.2.1 Overview
- 7.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Heterotopic Heart Transplant
- 7.3.1 Overview
- 7.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)

8. Heart Transplant Market Analysis - Type

8.1 Overview
8.2 Donor Live Heart
- 8.2.1 Overview
- 8.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Artificial Hearts
- 8.3.1 Overview
- 8.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
- 8.3.3 Ventricular Assisted Device
- 8.3.4 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
- 8.3.5 Total Artificial Heart
- 8.3.6 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)

9. Heart Transplant Market Analysis - End User

9.1 Overview
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Cardiac Centers
- 9.3.1 Overview
- 9.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Heart Transplant Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North American Transplant Market Overview
- 10.2.2 North America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
- 10.2.3 North America Heart Transplant Market Revenue and Forecasts and Analysis - By Surgery Type
- 10.2.4 North America Heart Transplant Market Revenue and Forecasts and Analysis - By Type
  - 10.2.4.1 North America Heart Transplant Market Revenue and Forecasts and Analysis - By Artificial Hearts
- 10.2.5 North America Heart Transplant Market Revenue and Forecasts and Analysis - By End User
- 10.2.6 North America Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.2.6.1 US: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.2.6.1.3 United States Heart Transplant Market Breakdown by Surgery Type
    - 10.2.6.1.4 United States Heart Transplant Market Breakdown by Type
    - 10.2.6.1.4.1 United States Heart Transplant Market Breakdown by Artificial Hearts
    - 10.2.6.1.5 United States Heart Transplant Market Breakdown by End User
  - 10.2.6.2 Canada: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.2.6.2.3 Canada Heart Transplant Market Breakdown by Surgery Type
    - 10.2.6.2.4 Canada Heart Transplant Market Breakdown by Type
    - 10.2.6.2.4.1 Canada Heart Transplant Market Breakdown by Artificial Hearts
    - 10.2.6.2.5 Canada Heart Transplant Market Breakdown by End User
  - 10.2.6.3 Mexico: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.2.6.3.3 Mexico Heart Transplant Market Breakdown by Surgery Type
    - 10.2.6.3.4 Mexico Heart Transplant Market Breakdown by Type
    - 10.2.6.3.4.1 Mexico Heart Transplant Market Breakdown by Artificial Hearts
    - 10.2.6.3.5 Mexico Heart Transplant Market Breakdown by End User
10.3 Europe
- 10.3.1 Europe Heart Transplant Market Overview
- 10.3.2 Europe Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
- 10.3.3 Europe Heart Transplant Market Revenue and Forecasts and Analysis - By Surgery Type
- 10.3.4 Europe Heart Transplant Market Revenue and Forecasts and Analysis - By Type
  - 10.3.4.1 Europe Heart Transplant Market Revenue and Forecasts and Analysis - By Artificial Hearts
- 10.3.5 Europe Heart Transplant Market Revenue and Forecasts and Analysis - By End User
- 10.3.6 Europe Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.3.6.1 Europe Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.3.6.2 Germany: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 Germany Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.3.6.2.3 Germany Heart Transplant Market Breakdown by Surgery Type
    - 10.3.6.2.4 Germany Heart Transplant Market Breakdown by Type
    - 10.3.6.2.4.1 Germany Heart Transplant Market Breakdown by Artificial Hearts
    - 10.3.6.2.5 Germany Heart Transplant Market Breakdown by End User
  - 10.3.6.3 France: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 France Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.3.6.3.3 France Heart Transplant Market Breakdown by Surgery Type
    - 10.3.6.3.4 France Heart Transplant Market Breakdown by Type
    - 10.3.6.3.4.1 France Heart Transplant Market Breakdown by Artificial Hearts
    - 10.3.6.3.5 France Heart Transplant Market Breakdown by End User
  - 10.3.6.4 United Kingdom: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 United Kingdom Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.3.6.4.3 United Kingdom Heart Transplant Market Breakdown by Surgery Type
    - 10.3.6.4.4 United Kingdom Heart Transplant Market Breakdown by Type
    - 10.3.6.4.4.1 United Kingdom Heart Transplant Market Breakdown by Artificial Hearts
    - 10.3.6.4.5 United Kingdom Heart Transplant Market Breakdown by End User
  - 10.3.6.5 Spain: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 Spain Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.3.6.5.3 Spain Heart Transplant Market Breakdown by Surgery Type
    - 10.3.6.5.4 Spain Heart Transplant Market Breakdown by Type
    - 10.3.6.5.4.1 Spain Heart Transplant Market Breakdown by Artificial Hearts
    - 10.3.6.5.5 Spain Heart Transplant Market Breakdown by End User
  - 10.3.6.6 Italy: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Italy Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.3.6.6.3 Italy Heart Transplant Market Breakdown by Surgery Type
    - 10.3.6.6.4 Italy Heart Transplant Market Breakdown by Type
    - 10.3.6.6.4.1 Italy Heart Transplant Market Breakdown by Artificial Hearts
    - 10.3.6.6.5 Italy Heart Transplant Market Breakdown by End User
  - 10.3.6.7 Rest of Europe
    - 10.3.6.7.1 Overview
    - 10.3.6.7.2 Rest of Europe Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.3.6.7.3 Rest of Europe Heart Transplant Market Breakdown by Surgery Type
    - 10.3.6.7.4 Rest of Europe Heart Transplant Market Breakdown by Type
    - 10.3.6.7.4.1 Rest of Europe Heart Transplant Market Breakdown by Artificial Hearts
    - 10.3.6.7.5 Rest of Europe Heart Transplant Market Breakdown by End User
10.4 Asia Pacific
- 10.4.1 Asia PacificHeart Transplant Market Overview
- 10.4.2 Asia Pacific Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
- 10.4.3 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By Surgery Type
- 10.4.4 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By Type
  - 10.4.4.1 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By Artificial Hearts
- 10.4.5 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By End User
- 10.4.6 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.4.6.1 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.4.6.2 China: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.6.2.1 Overview
    - 10.4.6.2.2 China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.4.6.2.3 China Heart Transplant Market Breakdown by Surgery Type
    - 10.4.6.2.4 China Heart Transplant Market Breakdown by Type
    - 10.4.6.2.4.1 China Heart Transplant Market Breakdown by Artificial Hearts
    - 10.4.6.2.5 China Heart Transplant Market Breakdown by End User
  - 10.4.6.3 India: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.6.3.1 Overview
    - 10.4.6.3.2 India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.4.6.3.3 India Heart Transplant Market Breakdown by Surgery Type
    - 10.4.6.3.4 India Heart Transplant Market Breakdown by Type
    - 10.4.6.3.4.1 India Heart Transplant Market Breakdown by Artificial Hearts
    - 10.4.6.3.5 India Heart Transplant Market Breakdown by End User
  - 10.4.6.4 South Korea: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.6.4.1 Overview
    - 10.4.6.4.2 South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.4.6.4.3 South Korea Heart Transplant Market Breakdown by Surgery Type
    - 10.4.6.4.4 South Korea Heart Transplant Market Breakdown by Type
    - 10.4.6.4.4.1 South Korea Heart Transplant Market Breakdown by Artificial Hearts
    - 10.4.6.4.5 South Korea Heart Transplant Market Breakdown by End User
  - 10.4.6.5 Japan: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.6.5.1 Overview
    - 10.4.6.5.2 Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.4.6.5.3 Japan Heart Transplant Market Breakdown by Surgery Type
    - 10.4.6.5.4 Japan Heart Transplant Market Breakdown by Type
    - 10.4.6.5.4.1 Japan Heart Transplant Market Breakdown by Artificial Hearts
    - 10.4.6.5.5 Japan Heart Transplant Market Breakdown by End User
  - 10.4.6.6 Australia: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.6.6.1 Overview
    - 10.4.6.6.2 Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.4.6.6.3 Australia Heart Transplant Market Breakdown by Surgery Type
    - 10.4.6.6.4 Australia Heart Transplant Market Breakdown by Type
    - 10.4.6.6.4.1 Australia Heart Transplant Market Breakdown by Artificial Hearts
    - 10.4.6.6.5 Australia Heart Transplant Market Breakdown by End User
  - 10.4.6.7 Rest of APAC: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.6.7.1 Overview
    - 10.4.6.7.2 Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.4.6.7.3 Rest of APAC Heart Transplant Market Breakdown by Surgery Type
    - 10.4.6.7.4 Rest of APAC Heart Transplant Market Breakdown by Type
    - 10.4.6.7.4.1 Rest of APAC Heart Transplant Market Breakdown by Artificial Hearts
    - 10.4.6.7.5 Rest of APAC Heart Transplant Market Breakdown by End User
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Heart Transplant Market Overview
- 10.5.2 Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
- 10.5.3 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis - By Surgery Type
- 10.5.4 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis - By Type
  - 10.5.4.1 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis - By Artificial Hearts
- 10.5.5 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis - By End User
- 10.5.6 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.5.6.1 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.5.6.2 Saudi Arabia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  - 10.5.6.3 Saudi Arabia: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.6.3.1 Overview
    - 10.5.6.3.2 Saudi Arabia Heart Transplant Market Breakdown by Surgery Type
    - 10.5.6.3.3 Saudi Arabia Heart Transplant Market Breakdown by Type
    - 10.5.6.3.3.1 Saudi Arabia Heart Transplant Market Breakdown by Artificial Hearts
    - 10.5.6.3.4 Saudi Arabia Heart Transplant Market Breakdown by End User
  - 10.5.6.4 South Africa: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.6.4.1 Overview
    - 10.5.6.4.2 South Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.5.6.4.3 South Africa Heart Transplant Market Breakdown by Surgery Type
    - 10.5.6.4.4 South Africa Heart Transplant Market Breakdown by Type
    - 10.5.6.4.4.1 South Africa Heart Transplant Market Breakdown by Artificial Hearts
    - 10.5.6.4.5 South Africa Heart Transplant Market Breakdown by End User
  - 10.5.6.5 UAE: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.6.5.1 Overview
    - 10.5.6.5.2 United Arab Emirates Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.5.6.5.3 United Arab Emirates Heart Transplant Market Breakdown by Surgery Type
    - 10.5.6.5.4 United Arab Emirates Heart Transplant Market Breakdown by Type
    - 10.5.6.5.4.1 United Arab Emirates Heart Transplant Market Breakdown by Artificial Hearts
    - 10.5.6.5.5 United Arab Emirates Heart Transplant Market Breakdown by End User
  - 10.5.6.6 Rest of Middle East & Africa: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.6.6.1 Overview
    - 10.5.6.6.2 Rest of Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.5.6.6.3 Rest of Middle East and Africa Heart Transplant Market Breakdown by Surgery Type
    - 10.5.6.6.4 Rest of Middle East and Africa Heart Transplant Market Breakdown by Type
    - 10.5.6.6.4.1 Rest of Middle East and Africa Heart Transplant Market Breakdown by Artificial Hearts
    - 10.5.6.6.5 Rest of Middle East and Africa Heart Transplant Market Breakdown by End User
10.6 South and Central America
- 10.6.1 South and Central America Heart Transplant Market Overview
- 10.6.2 South and Central America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
- 10.6.3 South and Central America Heart Transplant Market Revenue and Forecasts and Analysis - By Surgery Type
- 10.6.4 South and Central America Heart Transplant Market Revenue and Forecasts and Analysis - By Type
  - 10.6.4.1 South and Central America Heart Transplant Market Revenue and Forecasts and Analysis - By Artificial Hearts
- 10.6.5 South and Central America Heart Transplant Market Revenue and Forecasts and Analysis - By End User
- 10.6.6 South and Central America Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.6.6.1 South and Central America Heart Transplant Market Revenue and Forecasts and Analysis - By Country
  - 10.6.6.2 Brazil: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.6.6.2.1 Overview
    - 10.6.6.2.2 Brazil Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.6.6.2.3 Brazil Heart Transplant Market Breakdown by Surgery Type
    - 10.6.6.2.4 Brazil Heart Transplant Market Breakdown by Type
    - 10.6.6.2.4.1 Brazil Heart Transplant Market Breakdown by Artificial Hearts
    - 10.6.6.2.5 Brazil Heart Transplant Market Breakdown by End User
  - 10.6.6.3 Argentina: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.6.6.3.1 Overview
    - 10.6.6.3.2 Argentina Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.6.6.3.3 Argentina Heart Transplant Market Breakdown by Surgery Type
    - 10.6.6.3.4 Argentina Heart Transplant Market Breakdown by Type
    - 10.6.6.3.4.1 Argentina Heart Transplant Market Breakdown by Artificial Hearts
    - 10.6.6.3.5 Argentina Heart Transplant Market Breakdown by End User
  - 10.6.6.4 Rest of South and Central America: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.6.6.4.1 Overview
    - 10.6.6.4.2 Rest of South and Central America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.6.6.4.3 Rest of South and Central America Heart Transplant Market Breakdown by Surgery Type
    - 10.6.6.4.4 Rest of South and Central America Heart Transplant Market Breakdown by Type
    - 10.6.6.4.4.1 Rest of South and Central America Heart Transplant Market Breakdown by Artificial Hearts
    - 10.6.6.4.5 Rest of South and Central America Heart Transplant Market Breakdown by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Heart Transplant Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. COMPANY PROFILES

12.1 Terumo Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Evaheart Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Abbott Laboratories
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 SynCardia Systems LLC
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BiVACOR Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BioVentrix Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Berlin Heart GmbH
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 LivaNova Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Jarvik Heart Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Calon Cardio-Technology Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,204,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 8,993,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 11,781,000

※ 부가세 별도